Dr. Dan Olson of the University of Chicago joins the Healthcare Unfiltered EXPRESS to discuss the current state of TILs in cancer therapy, specifically in melanoma. Dr. Olson describes the technology, how to deliver, how to mitigate side effects, and offers valuable insights on future directions. A mist listen - please share, review, and subscribe.